These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, Sigal-Zafrani B, Mignot L, Sastre-Garau X, Pierga JY, Institut Curie Breast Cancer Study Group. Clin Cancer Res; 2008 Jun 01; 14(11):3306-11. PubMed ID: 18519757 [Abstract] [Full Text] [Related]
4. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients. Fehm T, Banys M, Rack B, Jäger B, Hartkopf A, Taran FA, Janni W. Int J Cancer; 2014 Feb 15; 134(4):925-31. PubMed ID: 23921989 [Abstract] [Full Text] [Related]
5. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer. Wimberger P, Heubner M, Otterbach F, Fehm T, Kimmig R, Kasimir-Bauer S. Gynecol Oncol; 2007 Nov 15; 107(2):331-8. PubMed ID: 17764727 [Abstract] [Full Text] [Related]
6. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. Janni W, Hepp F, Strobl B, Rack B, Rjosk D, Kentenich C, Schindlbeck C, Hantschmann P, Pantel K, Sommer H, Braun S. Cancer; 2003 Jan 15; 97(2):405-11. PubMed ID: 12518364 [Abstract] [Full Text] [Related]
10. Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients. Solomayer EF, Becker S, Pergola-Becker G, Bachmann R, Krämer B, Vogel U, Neubauer H, Wallwiener D, Huober J, Fehm TN. Breast Cancer Res Treat; 2006 Jul 15; 98(2):179-84. PubMed ID: 16552629 [Abstract] [Full Text] [Related]
12. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators. Hofmann T, Riesenberg R, Buchner A, Zimmermann W, Hofstetter A, Oberneder R. J Urol; 2003 Apr 15; 169(4):1303-7. PubMed ID: 12629348 [Abstract] [Full Text] [Related]
13. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B. Breast Cancer Res Treat; 2011 Feb 15; 125(3):729-38. PubMed ID: 20449649 [Abstract] [Full Text] [Related]
15. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas. Schindlbeck C, Kampik T, Janni W, Rack B, Jeschke U, Krajewski S, Sommer H, Friese K. Breast Cancer Res; 2005 Feb 15; 7(6):R1174-85. PubMed ID: 16457698 [Abstract] [Full Text] [Related]
19. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer. Fehm T, Banys M, Rack B, Janni W, Marth C, Blassl C, Hartkopf A, Trope C, Kimmig R, Krawczyk N, Wallwiener D, Wimberger P, Kasimir-Bauer S. Int J Gynecol Cancer; 2013 Jun 15; 23(5):839-45. PubMed ID: 23694981 [Abstract] [Full Text] [Related]
20. [Incidence and prognostic significance of disseminated tumor cells in patients with cervical cancer]. Rack B, Janni W, Kentenich C, Strobl B, Klanner E, Schindlbeck C, Hepp F, Sommer H, Braun S. Acta Med Austriaca Suppl; 2002 Jun 15; 59():36-41. PubMed ID: 12506759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]